期刊文献+

肺动脉高压对内皮祖细胞与骨形成蛋白-2的影响 被引量:1

The effection of idiopathic pulmonary hypertension on endothelial progenitor cells and bone morphogenetic protein-2
下载PDF
导出
摘要 目的分析特发性肺动脉高压(IPAH)对血浆骨形成蛋白2(BMP-2)的浓度和外周血内皮祖细胞(EPC)数量的影响以及BMP-2与肺动脉压(PAP)及EPC的关系。方法选取经右心漂浮导管检测肺动脉压确诊的IPAH住院患者28例为试验组;同时选取健康志愿者20例为对照组。采用酶联免疫吸附法(enzyme linked immunosorbent assay,ELISA)法测定血浆BMP-2的浓度,同时显微镜下计数外周血EPC。统计分析两组差异并对BMP-2与PAP和EPC的相关性进行分析。结果 IPAH患者血浆BMP-2水平高于对照组,差异有统计学意义[(0.1294±0.0292)μg/mlvs.(0.0898±0.0295)μg/ml,P<0.01],外周血EPC数量低于正常对照组,EPC数量具差异有统计学意义[(26.75±5.87)个vs.(42.65±8.37)个,P<0.01]。BMP-2与PAP呈正相关,与EPC数量呈负相关。结论血浆BMP-2升高及EPC数量下降可能参与IPAH的发病过程;且BMP-2与PAP和EPC均有关。 Objective To investigate the effectiong of idiopathic pulmonary arterial hypertension ( IPAH ) on bone morphogenetic protein-2 ( BMP-2 ) and counts of endothelial progenitor cells ( EPC ) , and the co relationg between and BMP-2 and pulmary arterial pressure(PAP) and the counts of EPC. Methods The patients with IPAH ( n =28 ) diagnosed by the examination of right heart floating catheters for pulmonary arterial pressure were selected as experimental group, and healthy volunteers were selected as control group. The concentration of plasma BMP-2 was detected by using enzyme-linked immunosorbent assay ( ELISA ) and EPC in peripheral blood were counted under the microscope. Results The difference in plasma BMP-2 had statistical significance between IPAN group and contrlo group [ ( 0.1294 ± 0.0292 )μ g/mL vs.( 0.0898 ± 0.0295 )μ g/mL, P 0.01], and the difference in EPC counts also had statistical significance [ ( 26.75 ± 5.87 ) piece vs.( 42.65 ± 8.37 ) piece, P 0.01]. The relation of BMP-2 and PAP was positive, while negative between BMP-2 and EPC. Conclusion IPAH caused the increase of BMP-2 while desease of EPC, the relation between BMP-2 and PAP or BMP-2 and EPC was existed in IPAH patients.
出处 《中国循证心血管医学杂志》 2012年第5期462-464,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
关键词 特发性肺动脉高压 骨形成蛋白-2 内皮祖细胞 Idiopathic pulmonary arterial hypertension Bone morphogenetic protein-2 Endothelial progenitor cells
  • 相关文献

参考文献9

  • 1Cool CD,Stewart JS,Werahera P,et al. Three-dimensionalreconstruction of pulmonary arteries in plexiform pulmonaryhypertension using cell-specific marlcenevidence for a dynamic andheterogeneous process of pulmonary endothelial cell growth[J]. Am JPathol,1999,155(2):411-9.
  • 2Janssen LJ,Rindermann M,Barth U,et at. Linkage analysis in a largefamily with PPH:genelic heterogeneity and a second PPH locus on 2q3132[J]. Chest,2002,121(3Suppl):54S-6S.
  • 3Spinella-Jaegle S,Roman-roman S,Faucheu C,et al. Opposite effectsof bone morphogenetic protein-2 and transforming growth factor beta1on osteoblast differentiation[J].Bone,2001,29(4):323-30.
  • 4Teichert-Kuliszewska K,Kutryk MJ,Kuliszewski MA,et al. Bonemorphogenetic protein receptor-2 signaling promotes pulmonaryarterial endothelial cell survival: implications for loss-of-functionmutations in the pathogenesis of pulmonary hypertension[J]. CircRes,2006,98 ⑵:209-17.
  • 5Vasa M,Fichtlscherer S’Aicher K,et al. Number and MigratoryActivity of Circulating Endothelial Progenitor Cells InverselyCorrelate With Risk Factors for Coronary Artery Disease[J]. CircRes,2001,89(l):El-7.
  • 6Rhodes CJ, Howard LS, Busbridge M,et al. Iron deficiency and raisedhepcidin in idiopathic pulmonary arterial hypertension: clinicalprevalence, outcomes, and mechanistic insights[J]. Am Coll Cardiol,2011,58(3):300-9.
  • 7Tuder RM,Voelkel NF. Angiogenesis and pulmonary hypertension: aunique process in a unique disease [J]. Antioxid Redox Signal,2002,4,(5):833-43.
  • 8Kalka C,Masuda H,Takahashi H,et al. Transplantation of exvivo expanded endothelial progenitor cells for therapeuticneovascularization[J]. Proc Natl Acad Sci USA,2000,97(7):3422-7.
  • 9Murohara T. Therapeutic vasculogenesis uring human cord blood-derived endothelial progenitors[J]. Trends Cardiovasc Med,2001,11(8):303-7.

同被引文献22

  • 1荆志成.2010年中国肺高血压诊治指南[J].中国医学前沿杂志(电子版),2011,3(2):62-81. 被引量:118
  • 2张韩,陈君柱.骨生成蛋白及其受体信号途径和肺动脉高压[J].国际心血管病杂志,2007,34(3):186-188. 被引量:1
  • 3Hoffman JI, Kaplan S. The incidence of congenital heart disease[J]. J Am Coil Cardiol, 2002,39:1890-1900.
  • 4Li W, Dunmore BJ, Morrell NW. Bone morphogenetic protein type II receptor mutations causing protein misfolding in heritable pulmonary arterial hypertension[J]. Proc Am Thorac Soc, 2010, 7 (6) :395-398.
  • 5Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation :molecular clones and activities[J]. Science, 1988, 242 : 1528-34.
  • 6Yuasa S, Itabashi Y, Koshimizu U, et al. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells[J]. Nature Biotechnol, 2005,23 : 607-11.
  • 7Schultheiss TM, Burch JB, Lassar AB. A role for bone morphogenetic proteins in the induction of cardiac myogenesis[J]. Genes Dev, 1997, 11:451-62.
  • 8Deng Z, Morse JH, Slager S, et al. Familial pulmonary hypertension (gene PPH1 )is caused by mutations in the bone morphogenetic protein reeeptor-II gene[J]. Am J Hum Genet, 2000,67:737-4.
  • 9Machado RD, Pauciulo MW, Thomson JR, et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension[J]. Am J Hum Genet, 2001,68 : 92-102.
  • 10Thomson JR, Machado RD, Pauciulo MW, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-IIBMPR2, a receptor member of the TGF-family[J]. J Med Genet, 2000, 37:741-75.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部